ID

13894

Descripción

A Feasibility Study on Adaptive 18F-FDG-guided Radiotherapy for Recurrent and Second Primary Head and Neck Cancer in the Previously Irradiated Territory.; ODM derived from: https://clinicaltrials.gov/show/NCT01427010

Link

https://clinicaltrials.gov/show/NCT01427010

Palabras clave

Versiones (1)
  1. 13/3/16 13/3/16 -
Subido en

13 de marzo de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Recurrent and Second Primary Squamous Cell Carcinoma of the Oral Cavity in the Previously Irradiated Territory in Case of Primary Unresectable Tumor. NCT01427010

Inglés

Eligibility Recurrent and Second Primary Squamous Cell Carcinoma of the Oral Cavity in the Previously Irradiated Territory in Case of Primary Unresectable Tumor. NCT01427010

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically confirmed recurrences and second primary squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx or larynx in the previously irradiated territory.
Descripción

recurrence squamous cell carcinoma of the oral cavity

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0034897
UMLS CUI [1,2]
C0585362
primary unresectable tumor and/or patients refused surgery.
Descripción

Tumor surgically unresectable

Tipo de datos

boolean

Alias
UMLS CUI [1]
C4039777
no grade 3 or more late toxicity (except xerostomia) after the initial radio(chemo)therapy for primary head and neck cancer.
Descripción

late toxicity; xerostomia; Chemoradiotherapy; Cancer of Head and Neck

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2198186
UMLS CUI [2]
C0043352
UMLS CUI [3]
C0436307
UMLS CUI [4]
C0278996
minimal interval 12 months after the initial radio(chemo)therapy for primary head and neck cancer.
Descripción

Chemoradiotherapy; Cancer of Head and Neck

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0436307
UMLS CUI [2]
C0278996
decision of a multidisciplinary tumor board on curative radiotherapy (in combination or not with targeted therapy with cetuximab)
Descripción

radiotherapy; Targeted Therapy; cetuximab

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1522449
UMLS CUI [2]
C2985566
UMLS CUI [3]
C0995188
karnofsky performance status ≥70%.
Descripción

karnofsky performance status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0206065
age ≥ 18 years old.
Descripción

age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
informed consent obtained, signed and dated before specific protocol procedures.
Descripción

informed consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
previous radiotherapy for ct1-2 cn0 m0 glottic cancer.
Descripción

radiotherapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1522449
brachytherapy as treatment for second primary / recurrence.
Descripción

brachytherapy; recurrence

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0034897
distant metastases.
Descripción

metastases

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0027627
other second primary tumors that are not under control.
Descripción

primary tumor

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0677930
pregnant or lactating women.
Descripción

pregnancy; lactating

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
elevated blood creatinine level.
Descripción

blood creatinine level

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3516328
allergy to the ct-contrast agents.
Descripción

hypersensitivity contrast agent

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0009924
mental condition rendering the patient unable to understand the nature, scope, and possible consequences of the study.
Descripción

Compliance behavior Limited mental condition

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1321605
UMLS CUI [1,2]
C0439801
UMLS CUI [1,3]
C3840291
patient unlikely to comply with protocol, i.e. uncooperative attitude, inability to return for follow-up visits, and unlikely to complete the study.
Descripción

compliance

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1321605
Volver a la parte superior de la página

Similar models

Eligibility Recurrent and Second Primary Squamous Cell Carcinoma of the Oral Cavity in the Previously Irradiated Territory in Case of Primary Unresectable Tumor. NCT01427010

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
recurrence squamous cell carcinoma of the oral cavity
Item
histologically confirmed recurrences and second primary squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx or larynx in the previously irradiated territory.
boolean
C0034897 (UMLS CUI [1,1])
C0585362 (UMLS CUI [1,2])
Tumor surgically unresectable
Item
primary unresectable tumor and/or patients refused surgery.
boolean
C4039777 (UMLS CUI [1])
late toxicity; xerostomia; Chemoradiotherapy; Cancer of Head and Neck
Item
no grade 3 or more late toxicity (except xerostomia) after the initial radio(chemo)therapy for primary head and neck cancer.
boolean
C2198186 (UMLS CUI [1])
C0043352 (UMLS CUI [2])
C0436307 (UMLS CUI [3])
C0278996 (UMLS CUI [4])
Chemoradiotherapy; Cancer of Head and Neck
Item
minimal interval 12 months after the initial radio(chemo)therapy for primary head and neck cancer.
boolean
C0436307 (UMLS CUI [1])
C0278996 (UMLS CUI [2])
radiotherapy; Targeted Therapy; cetuximab
Item
decision of a multidisciplinary tumor board on curative radiotherapy (in combination or not with targeted therapy with cetuximab)
boolean
C1522449 (UMLS CUI [1])
C2985566 (UMLS CUI [2])
C0995188 (UMLS CUI [3])
karnofsky performance status
Item
karnofsky performance status ≥70%.
boolean
C0206065 (UMLS CUI [1])
age
Item
age ≥ 18 years old.
boolean
C0001779 (UMLS CUI [1])
informed consent
Item
informed consent obtained, signed and dated before specific protocol procedures.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
radiotherapy
Item
previous radiotherapy for ct1-2 cn0 m0 glottic cancer.
boolean
C1522449 (UMLS CUI [1])
brachytherapy; recurrence
Item
brachytherapy as treatment for second primary / recurrence.
boolean
C0034897 (UMLS CUI [1])
metastases
Item
distant metastases.
boolean
C0027627 (UMLS CUI [1])
primary tumor
Item
other second primary tumors that are not under control.
boolean
C0677930 (UMLS CUI [1])
pregnancy; lactating
Item
pregnant or lactating women.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
blood creatinine level
Item
elevated blood creatinine level.
boolean
C3516328 (UMLS CUI [1])
hypersensitivity contrast agent
Item
allergy to the ct-contrast agents.
boolean
C0020517 (UMLS CUI [1,1])
C0009924 (UMLS CUI [1,2])
Compliance behavior Limited mental condition
Item
mental condition rendering the patient unable to understand the nature, scope, and possible consequences of the study.
boolean
C1321605 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C3840291 (UMLS CUI [1,3])
compliance
Item
patient unlikely to comply with protocol, i.e. uncooperative attitude, inability to return for follow-up visits, and unlikely to complete the study.
boolean
C1321605 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial